ACE2 and acute respiratory distress syndrome: Another difference may be the prolonged course of COVID-19 and ARDS in critically ill patients, which may be accompanied by a dysregulated interferon response as a stimulus for ACE2 expression, as opposed to the relatively short duration of experiments modeling ARDS in animals (Gerard et al., 2021).